Methods for the amplification of bisulfite-treated DNA
The methods, compositions, and kits of the disclosure provide a novel approach for a whole genome, unbiased DNA analysis method that can be performed on limited amounts of DNA. can be used to analyze DNA to determine its modification status. Aspects of the disclosure relate to a method for amplifying bisulfite-treated deoxyribonucleic acid (DNA) molecules comprising: (a) ligating an adaptor to the DNA molecules, wherein the adaptor comprises a RNA polymerase promoter comprising bisulfite-protected cytosines; (b) treating the ligated DNA molecules with bisulfite; (c) hybridizing the bisulfite-treated DNA molecules with a primer; (d) extending the hybridized primer to make double stranded DNA; and (e) in vitro transcribing the double-stranded DNA to make RNA.
1. A kit comprising a DNA adaptor comprising a RNA promoter, wherein the cytosines of the RNA promoter are bisulfite-protected.
2. The kit of claim 1 , further comprising a ligase and/or ligase buffer.
3. The kit of claim 1 further comprising bisulfite.
4. The kit of claim 1 further comprising a primer that is complementary to the adaptor.
5. The kit of claim 1 further comprising dNTPs.
6. The kit of claim 1 further comprising a DNA polymerase.
7. The kit of claim 1 further comprising nuclease-free water.
8. The kit of claim 1 further comprising a protease.
9. The kit of claim 1 further comprising a RNA polymerase and/or reverse transcriptase.
10. The kit of claim 1 further comprising NTPs.
11. The kit of claim 1 further comprising an oxidant.
12. The kit of claim 1 further comprising a dioxygenase.
13. The kit of claim 1 further comprising a compound comprising a hydroxylamine group, a hydrazine group, or a hydrazide group.
14. The kit of claim 1 further comprising a compound comprising an amine group.
15. The kit of claim 1 further comprising a 3′ end-blocked molecule.
16. The kit of claim 1 further comprising SPRI beads.
17. The kit of claim 1 further comprising glucose or modified glucose.
18. The kit of claim 1 further comprising (3-glucosyltransferase.